Correlation Between Enzymatica Publ and Unibap AB

Can any of the company-specific risk be diversified away by investing in both Enzymatica Publ and Unibap AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enzymatica Publ and Unibap AB into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Enzymatica publ AB and Unibap AB, you can compare the effects of market volatilities on Enzymatica Publ and Unibap AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enzymatica Publ with a short position of Unibap AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enzymatica Publ and Unibap AB.

Diversification Opportunities for Enzymatica Publ and Unibap AB

-0.68

Correlation Coefficient

Enzymatica Publ  Unibap AB

Excellent diversification

The 3 months correlation between Enzymatica and Unibap is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Enzymatica publ AB and Unibap AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unibap AB and Enzymatica Publ is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enzymatica publ AB are associated (or correlated) with Unibap AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unibap AB has no effect on the direction of Enzymatica Publ i.e., Enzymatica Publ and Unibap AB go up and down completely randomly.

Pair Corralation between Enzymatica Publ and Unibap AB

Assuming the 90 days trading horizon Enzymatica publ AB is expected to generate 0.79 times more return on investment than Unibap AB. However, Enzymatica publ AB is 1.26 times less risky than Unibap AB. It trades about -0.02 of its potential returns per unit of risk. Unibap AB is currently generating about -0.02 per unit of risk. If you would invest  470.00  in Enzymatica publ AB on September 26, 2024 and sell it today you would lose (307.00) from holding Enzymatica publ AB or give up 65.32% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Enzymatica publ AB  vs.  Unibap AB

Enzymatica publ AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Enzymatica publ AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Unibap AB

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Unibap AB are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain forward indicators, Unibap AB sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Enzymatica Publ and Unibap AB

The main advantage of trading using opposite Enzymatica Publ and Unibap AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enzymatica Publ position performs unexpectedly, Unibap AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unibap AB will offset losses from the drop in Unibap AB's long position.

The idea behind Enzymatica publ AB and Unibap AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.